Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia

Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia

Lipocalin 2 (LCN2) has been recently identified as an endogenous regulator of appetite. Here, using pancreatic cancer as a model of cachexia, the authors demonstrate that LCN2 is a critical mediator of cancer-associated anorexia and may be therapeutically targeted to improve patient outcomes.

Saved in:
Bibliographic Details
Main Authors: Brennan Olson, Xinxia Zhu, Mason A. Norgard, Peter R. Levasseur, John T. Butler, Abigail Buenafe, Kevin G. Burfeind, Katherine A. Michaelis, Katherine R. Pelz, Heike Mendez, Jared Edwards, Stephanie M. Krasnow, Aaron J. Grossberg, Daniel L. Marks
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Science
Q
Online Access:https://doaj.org/article/abf8c7f4da7a45d4af0d1631fd583659
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/abf8c7f4da7a45d4af0d1631fd583659

Similar Items